107 related articles for article (PubMed ID: 8813554)
41. Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma-[35S]thiotriphosphate binding to liposomes with varying muscarinic receptor/Go protein stoichiometry.
Jakubík J; Haga T; Tucek S
Mol Pharmacol; 1998 Nov; 54(5):899-906. PubMed ID: 9804625
[TBL] [Abstract][Full Text] [Related]
42. Muscarinic binding sites on bovine pulmonary arterial endothelial cells in culture.
Aronstam RS; Ryan US; Catravas JD
Pharmacology; 1992; 44(6):324-33. PubMed ID: 1508962
[TBL] [Abstract][Full Text] [Related]
43. Heterogeneity of binding of muscarinic receptor antagonists in rat brain homogenates.
Lee JH; el-Fakahany EE
J Pharmacol Exp Ther; 1985 Jun; 233(3):707-14. PubMed ID: 3839264
[TBL] [Abstract][Full Text] [Related]
44. Characterization of 3H-N-methylscopolamine binding to intact rat thymocytes.
Rinner I; Porta S; Schauenstein K
Endocrinol Exp; 1990 Mar; 24(1-2):125-32. PubMed ID: 2361455
[TBL] [Abstract][Full Text] [Related]
45. M2 receptor binding of the selective antagonist AF-DX 384: possible involvement of the common allosteric site.
Tränkle C; Andresen I; Lambrecht G; Mohr K
Mol Pharmacol; 1998 Feb; 53(2):304-12. PubMed ID: 9463489
[TBL] [Abstract][Full Text] [Related]
46. Kinetic studies of co-operativity at atrial muscarinic M2 receptors with an "infinite dilution" procedure.
Christopoulos A; Lanzafame A; Ziegler A; Mitchelson F
Biochem Pharmacol; 1997 Mar; 53(6):795-800. PubMed ID: 9113100
[TBL] [Abstract][Full Text] [Related]
47. [3H]N-Methylscopolamine binding to muscarinic receptors in intact adult rat brain cell aggregates.
Lee JH; el-Fakahany EE
Biochem Pharmacol; 1985 Dec; 34(24):4299-303. PubMed ID: 4074390
[TBL] [Abstract][Full Text] [Related]
48. Influence of monovalent cations on the binding of a charged and an uncharged ('carbo'-)muscarinic antagonist to muscarinic receptors.
Hou X; Wehrle J; Menge W; Ciccarelli E; Wess J; Mutschler E; Lambrecht G; Timmerman H; Waelbroeck M
Br J Pharmacol; 1996 Mar; 117(5):955-61. PubMed ID: 8851517
[TBL] [Abstract][Full Text] [Related]
49. Thermodynamics of antagonist binding to rat muscarinic M2 receptors: antimuscarinics of the pridinol, sila-pridinol, diphenidol and sila-diphenidol type.
Waelbroeck M; Camus J; Tastenoy M; Lambrecht G; Mutschler E; Kropfgans M; Sperlich J; Wiesenberger F; Tacke R; Christophe J
Br J Pharmacol; 1993 Jun; 109(2):360-70. PubMed ID: 8102927
[TBL] [Abstract][Full Text] [Related]
50. Identification of drugs competing with d-tubocurarine for an allosteric site on cardiac muscarinic receptors.
Waelbroeck M
Mol Pharmacol; 1994 Oct; 46(4):685-92. PubMed ID: 7969047
[TBL] [Abstract][Full Text] [Related]
51. Bretylium tosylate binds preferentially to muscarinic receptors labelled with [3H]oxotremorine M (SH or 'high affinity' receptors) in rat heart and brain cortex.
Gillard M; Brunner F; Waelbroeck M; Svoboda M; Christophe J
Eur J Pharmacol; 1989 Jan; 160(1):117-24. PubMed ID: 2714357
[TBL] [Abstract][Full Text] [Related]
52. Influence of pH on the binding of scopolamine and N-methylscopolamine to muscarinic receptors in the corpus striatum and heart of rats.
Ehlert FJ; Delen FM
Mol Pharmacol; 1990 Jul; 38(1):143-7. PubMed ID: 2370852
[TBL] [Abstract][Full Text] [Related]
53. Detection, quantitation, and verification of allosteric interactions of agents with labeled and unlabeled ligands at G protein-coupled receptors: interactions of strychnine and acetylcholine at muscarinic receptors.
Lazareno S; Birdsall NJ
Mol Pharmacol; 1995 Aug; 48(2):362-78. PubMed ID: 7651370
[TBL] [Abstract][Full Text] [Related]
54. Heparin, dextran and trypan blue allosterically modulate M2 muscarinic receptor binding properties and interfere with receptor-mediated inhibition of adenylate cyclase.
Gerstin EH; Luong T; Ehlert FJ
J Pharmacol Exp Ther; 1992 Dec; 263(3):910-7. PubMed ID: 1281880
[TBL] [Abstract][Full Text] [Related]
55. Binding properties of nine 4-diphenyl-acetoxy-N-methyl-piperidine (4-DAMP) analogues to M1, M2, M3 and putative M4 muscarinic receptor subtypes.
Waelbroeck M; Camus J; Tastenoy M; Christophe J
Br J Pharmacol; 1992 Jan; 105(1):97-102. PubMed ID: 1596694
[TBL] [Abstract][Full Text] [Related]
56. Muscarinic receptor heterogeneity in rat central nervous system. II. Brain receptors labeled by [3H]oxotremorine-M correspond to heterogeneous M2 receptors with very high affinity for agonists.
Gillard M; Waelbroeck M; Christophe J
Mol Pharmacol; 1987 Jul; 32(1):100-8. PubMed ID: 3600611
[TBL] [Abstract][Full Text] [Related]
57. Selective enhancement of antagonist ligand binding at muscarinic M2 receptors by heparin due to receptor uncoupling.
Wang SZ; Edmundson R; Zhu SZ; el-Fakahany EE
Eur J Pharmacol; 1996 Jan; 296(1):113-8. PubMed ID: 8720484
[TBL] [Abstract][Full Text] [Related]
58. Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptors.
Gnagey A; Ellis J
Biochem Pharmacol; 1996 Dec; 52(11):1767-75. PubMed ID: 8986140
[TBL] [Abstract][Full Text] [Related]
59. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist.
Grossmüller M; Antony J; Tränkle C; Holzgrabe U; Mohr K
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):267-76. PubMed ID: 16362429
[TBL] [Abstract][Full Text] [Related]
60. M2-muscarinic receptors: how does ligand binding affinity relate to intrinsic activity?
Van Gelderen JG; Daeffler L; Scherrer D; Mousli M; Landry Y; Gies JP
J Recept Signal Transduct Res; 1996; 16(1-2):135-48. PubMed ID: 8771535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
